Journal of Vaccines & Vaccination

Department of Medical Science, Ethiopian Public Health Institute, Addis Ababa, Ethiopia

Publications

• Research Article   
  The Status of Rabies Post Exposure Prophylaxis Using Nerve Tissue Anti-Rabies Vaccine in Ethiopia
  Author(s): Abebe M Aga*, Mekoro Beyene, Anberbir Alemu, Fiseha Alemayehu, Tigist Abebe, Gemechis Motuma, Demise Mulugeta, Jemal Mohamed, Efrem Emana, Serkadis Oljira and Birhanu Hurisa
  
  The use of anti-rabies vaccine as post-exposure prophylaxis started during the year 1885 and play significant role in preventing rabies cases in humans. Since then, anti-rabies vaccines have undergone several developments in terms of safety and efficacy. Ethiopia has been producing nerve tissue anti-rabies vaccine since 1960s for post exposure prophylaxis. Such type of vaccine was discouraged by WHO due to its low immunogenicity and sever nerve complication. During the last years, anti-rabies vaccine needs increasing from time to time due to the lack of effective rabies prevention and control measures. Although nerve tissue vaccine production capacity increased significantly, still demand has not met. According to WHO report, from 0.14 to 7 out of 1000 people received this nerve tissue vaccine has the probability to develop vaccine associated complications. This study reveals that dur.. View more»
  

  DOI: 10.35248/2157-7560.24.15.569

  Abstract HTML PDF